Citation Impact
64 standout
Citing Papers
Nanocarriers address intracellular barriers for efficient drug delivery, overcoming drug resistance, subcellular targeting and controlled release
2024 Standout
Paradigm Shift: A Comprehensive Review of Ovarian Cancer Management in an Era of Advancements
2024 Standout
Works of M. Patrick Lowe being referenced
Phase II clinical trial of bevacizumab with albumin-bound paclitaxel in patients with recurrent, platinum-resistant primary epithelial ovarian or primary peritoneal carcinoma
2012
Author Peers
| Author | OG | Surgery | PRM | Reproductive Medicine | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|
| M. Patrick Lowe | 310 | 163 | 49 | 188 | 17 | 429 | |
| E. Ancona | 195 | 144 | 44 | 134 | 24 | 429 | |
| Junhua Liu | 1 | 7 | 3 | 49 | 879 | ||
| Gudrun B. Paulsen | 2 | 2 | 50 | 798 | |||
| M. J. Ruzmyn Vilcassim | 1 | 1 | 10 | 23 | 520 | ||
| Elisa Brighenti | 17 | 55 | 6 | 15 | 560 |
All Works
Loading papers...